The increased apoptotic resistance mediated by D2R‐mediated AMPK activation during the aripiprazole‐induced apoptosis suggests that prevention of D2R/AMPK activation in response to aripiprazole treatment might be a strategy to enhance the anticancer effects of aripiprazole in breast cancer cells. Here, DRD2 is linked to breast cancer.